Despite improved antimicrobial therapy and preventative practices, hospital acquired and ventilator associated pneumonia remain important causes of morbidity and mortality

HAP & VAP continues to challenge intensivists, microbiologists, ID physicians and laboratory staff alike, from initial diagnosis to choice of effective treatment regimens.

Presentation Details	Downloads
Diagnosis, definitions & treatment
Welcome and Overview Bob Masterton, Ayrshire	Download Video
Diagnosis & defi nitions of HAP/VAP – where are we now? Gary French, London	Download Video Download Slides
Treatment of HAP/VAP – strategies & challenges Ethan Rubinstein, Canada	Download Video Download Slides
Reducing patient harm
HAP/VAP care bundle interventions – a UK approach Bob Masterton, Ayrshire	Download Video Download Slides
Reducing patient harm in critical care: the matching Michigan experience Bradford Winters, Baltimore, USA	Download Video Download Slides
Advances in HAP/VAP management
The impact of non-antimicrobial interventions Duncan Wyncoll, London	Download Video Download Slides
The impact of recent antimicrobial interventions – the PK/PD debate & what the evidence says William Hope, Manchester	Download Video Download Slides
Novel biomarkers for infection & sepsis Paul Dark, Manchester	Download Video